close

Enter

Log in using OpenID

R&I: Cryptococcal Meningitis Global Clinical Trials Review Market- Size, Share, Global Trends 2014

embedDownload
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical
Cryptococcal Meningitis Global Clinical Trials
Review, H2, 2014
Published: Nov 2014
No. of Pages: 76
Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials
Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial
scenario. This report provides elemental information and data relating to the
clinical trials on Cryptococcal Meningitis. It includes an overview of the trial
numbers and their recruitment status as per the site of trial conduction across
the globe. The databook offers a preliminary coverage of disease clinical trials
by their phase, trial status, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for treating
Cryptococcal Meningitis. This report is built using data and information sourced
from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South and
Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects
recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status,
recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals
or Companies
Detailed report at:
http://www.reportsandintelligence.com/cryptococcal-meningitisglobal-clinical-trials-review-h2-2014-market
Table of Content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cryptococcal Meningitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to
Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to
Infectious Disease Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Cryptococcal Meningitis 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical
Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
TTY Biopharm Company Limited 31
Clinical Trial Overview of TTY Biopharm Company Limited 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Liposome Company, Inc 33
Clinical Trial Overview of Liposome Company, Inc 33
Alkermes Plc 34
Clinical Trial Overview of Alkermes Plc 34
Clinical Trial Overview of Top Institutes / Government 35
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious
Diseases 35
St. George's University of London 36
Clinical Trial Overview of St. George's University of London 36
University of Minnesota 37
Clinical Trial Overview of University of Minnesota 37
University of Oxford 38
Clinical Trial Overview of University of Oxford 38
University of Zimbabwe-Parirenyatwa Clinical Research Center 39
Clinical Trial Overview of University of Zimbabwe-Parirenyatwa Clinical
Research Center 39
Department of Biotechnology, India 40
Clinical Trial Overview of Department of Biotechnology, India 40
French National Agency for Research on AIDS and Viral Hepatitis 41
Clinical Trial Overview of French National Agency for Research on AIDS and
Viral Hepatitis 41
Five Key Clinical Profiles 42
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76
Get detailed TOC at:
http://www.reportsandintelligence.com/cryptococcal-meningitisglobal-clinical-trials-review-h2-2014-market/table-of-contents
Contact Us:
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email us: [email protected]
Web: http://www.reportsandintelligence.com
Facebook: https://www.facebook.com/reportsnintelligence
1/--pages
Report inappropriate content